Navigation Links
Weak Evidence Backs Most Heart Guidelines, Report Finds
Date:2/24/2009

Experts agree that field needs more rigorous trials to aid doctors,,

TUESDAY, Feb. 24 (HealthDay News) -- A majority of the guidelines for cardiac care issued by the American Heart Association and the American College of Cardiology are not supported by the kind of gold-standard evidence that doctors respect most, a new study finds.

That conclusion does not come from heretics crying in the wilderness. One author of the report, published in the Journal of the American Medical Association, is Dr. Sidney Smith, a professor of medicine at the University of North Carolina, a past president of the heart association and former chairman of the AHA/ACC Guidelines Task Force.

The findings were quickly endorsed by Dr. Timothy J. Gardner, current AHA president.

"There are many situations we encounter where we don't have as strong evidence for the guidelines as we would like to have," said Gardner, who is medical director of the Center for Heart & Vascular Health at the Christiana Care Health System in Delaware. "There haven't been enough randomized trials."

And too many of the carefully controlled trials now being done are financed by pharmaceutical companies, said Dr. Pierluigi Tricoci, a cardiologist at the Duke Heart Center and another member of the team that did the study.

"Most major clinical trials are sponsored by the pharmaceutical industry, because they want to bring products to market," Tricoci said. "We don't have a source of funding for those situations that the pharmaceutical industry might not be interested in. We should not be surprised that the pharmaceutical industry is not interested in trials from which they might not make money."

Tricoci was an originator of the project that looked at the evidence supporting cardiac care guidelines, which have multiplied in number in recent years. The project investigators examined 53 guidelines on 22 topics, with a total of 7,196 rec
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Jefferson researchers uncover new evidence of prolactins possible role in breast cancer
2. No strong evidence linking amateur boxing with long-term brain injury
3. AHRQ Announces Next Phase of Its Evidence-Based Practice Center Program
4. Vanderbilt Medical Center chosen as Evidence-based Practice Center
5. Little Evidence Silicone Breast Implants Harm Health
6. Consumers Should Demand Evidence, Not Guesswork, On Meat-Cancer Links
7. U of M study: Medicare lacks tools, incentives to enforce evidence-based coverage policies
8. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
9. Scientific evidence of the significant anti-cancer effect of milk thistle
10. Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace
11. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weak Evidence Backs Most Heart Guidelines, Report Finds
Weak Evidence Backs Most Heart Guidelines, Report Finds
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 1Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 2Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 1National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 2National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 4National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 5Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 1Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 2Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 3Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 4Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 5